Benazepril ve hidroklorotiyazid ve Moeksipril etkileşimi
Benazepril ve hidroklorotiyazid ve Moeksipril: her iki reçeteleme etiketi de bu kombinasyonu kontrendikasyon, kutulu uyarı veya kaçınma talimatı gibi en güçlü ifadelerle işaretliyor.
Reçeteyi yazan hekimin yönlendirmesi olmadan birlikte kullanmayın. Aşağıdaki etiket ifadeleri, FDA'nın kullandığı en güçlü ifadelerdir.
FDA etiketleri ne diyor
Kaynak: Benazepril ve hidroklorotiyazid (Lotensin HCT) etiketi · yürürlük tarihi 2026-02-24
Lotensin HCT is also contraindicated in patients who are hypersensitive to benazepril, to any other ACE inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs.
Like other ACE inhibitors, benazepril has been only rarely associated with hypotension in uncomplicated hypertensive patients.
The thiazide component of Lotensin HCT may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic-blocking drugs.
Other ACE inhibitors have had less than additive effects with beta-adrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.
Lotensin HCT should be used cautiously in patients receiving concomitant therapy with other antihypertensives.
Kaynak: Moeksipril (Moexipril Hydrochloride) etiketi · yürürlük tarihi 2026-01-23
Hypotension Moexipril hydrochloride can cause symptomatic hypotension, although, as with other ACE inhibitors, this is unusual in uncomplicated hypertensive patients treated with moexipril hydrochloride alone.
Symptomatic hypotension is most likely to occur in patients who have been salt- and volume- depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting.
Volume- and salt-depletion should be corrected and, in general, diuretics stopped, before initiating therapy with moexipril hydrochloride (see PRECAUTIONS, Drug Interactions , and ADVERSE REACTIONS ).
In these patients, moexipril hydrochloride therapy should be started under close medical supervision, and patients should be followed closely for the first two weeks of treatment and whenever the dose of moexipril or an accompanying diuretic is increased.
Although there were no instances of severe neutropenia (absolute neutrophil count < 500/mm 3 ) among patients given moexipril hydrochloride, as with other ACE inhibitors, monitoring of white blood cell counts should be considered for patients who have collagen-vascular disease, especially if the disease is associated with impaired renal function.
Bu ikisinden fazlasını mı kullanıyorsunuz? Etkileşimler üst üste biner. Tüm listenizi tek seferde kontrol edin; liste tarayıcınızda kalır.
Sorgulama aracında açTıbbi tavsiye değildir. Interaction Checker, FDA etiket metinlerini ve NIH bilgi sayfalarını alıntılar. Bir etkileşimin sizin için önemli olup olmadığı dozlara, zamanlamaya, böbrek ve karaciğer fonksiyonuna ve diğer sağlık durumlarına bağlıdır. Bir eczacıya veya reçeteyi yazan hekime danışarak doğrulayın.